The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Direct Transcriptional Up-regulation of Cyclooxygenase-2 by Hypoxia-Inducible Factor (HIF)-1 Promotes Colorectal Tumor Cell Survival and Enhances HIF-1 Transcriptional Activity during Hypoxia
Abstract
Cyclooxygenase (COX)-2, the inducible key enzyme for prostanoid biosynthesis, is overexpressed in most colorectal carcinomas and a subset of colorectal adenomas. Genetic, biochemical, and clinical evidence indicates an important role for COX-2 in colorectal tumorigenesis. Although COX-2 can be induced by aberrant growth factor signaling and oncogene activation during colorectal tumorigenesis, the role of microenvironmental factors such as hypoxia in COX-2 regulation remains to be elucidated. For the first time, we report that under hypoxic conditions COX-2 protein levels increase in colorectal adenoma and carcinoma cells. Rigorous analyses reveal that COX-2 up-regulation is transcriptional and is associated with hypoxia-inducible factor (HIF)-1alpha induction. Oligonucleotide pull-down and chromatin immunoprecipitation assays reveal that HIF-1alpha binds a hypoxia-responsive element on the COX-2 promoter. COX-2 up-regulation during hypoxia is accompanied by increased levels of prostaglandin E(2) (PGE(2)), which promote tumor cell survival under hypoxic conditions. In addition, elevated levels of PGE(2) in hypoxic colorectal tumor cells enhance vascular endothelial growth factor expression and HIF-1 transcriptional activity by activating the mitogen-activated protein kinase pathway, showing a potential positive feedback loop that contributes to COX-2 up-regulation during hypoxia. This study identifies COX-2 as a direct target for HIF-1 in colorectal tumor cells. In addition, COX-2 up-regulation represents a pivotal cellular adaptive response to hypoxia with implication for colorectal tumor cell survival and angiogenesis. We propose that using modified COX-2-selective inhibitors, which are only activated under hypoxic conditions, could potentially be a novel more selective strategy for colorectal cancer prevention and treatment.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In addition, hypoxia also induces COX-2 [86].”
From The Pathogenesis of Adenomyosis vis-à-vis Endometriosis (2020) · cites this paper as [86]
Citations
Cites
Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
Hanahan, D., & Folkman, J. (1996) · Cell · doi:10.1016/s0092-8674(00)80108-7 · Cited by 6,885
Targeting HIF-1 for cancer therapy
Semenza, G. L. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1187 · Cited by 6,717
Wang, G. L., Jiang, B. H., Rue, E. A., & Semenza, G. L. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.12.5510 · Cited by 6,212
Jaakkola, P., Mole, D. R., Tian, Y.-M., Wilson, M. I., Gielbert, J., Gaskell, S. J., Kriegsheim, A. V., Hebestreit, H. F., Mukherji, M., Schofield, C. J., et al. (2001) · Science · doi:10.1126/science.1059796 · Cited by 5,535
Hypoxia — a key regulatory factor in tumour growth
Harris, A. L. (2002) · Nature Reviews Cancer · doi:10.1038/nrc704 · Cited by 5,177
Lessons from hereditary colorectal cancer
Kinzler, K. W., & Vogelstein, B. (1996) · Cell · doi:10.1016/s0092-8674(00)81333-1 · Cited by 4,919
The Effect of Celecoxib, a Cyclooxygenase-2 Inhibitor, in Familial Adenomatous Polyposis
Steinbach, G., Lynch, P. M., Phillips, R. K. S., Wallace, M. H., Hawk, E. T., Gordon, G., Wakabayashi, N., Saunders, B. P., Shen, Y., Fujimura, T., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200006293422603 · Cited by 2,522
Regulation of angiogenesis by hypoxia: role of the HIF system
Pugh, C. W., & Ratcliffe, P. J. (2003) · Nature Medicine · doi:10.1038/nm0603-677 · Cited by 2,520
Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas
Eberhart, C. E., Coffey, R. J., Aramandla, R., Giardiello, F. M., Ferrenbach, S., & DuBois, R. N. (1994) · Gastroenterology · doi:10.1016/0016-5085(94)90246-1 · Cited by 2,512
Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis
Carmeliet, P., Dor, Y., Herbert, J.-M., Fukumura, D., Brusselmans, K., Dewerchin, M., Neeman, M., Bono, F., Abramovitch, R., Maxwell, P., et al. (1998) · Nature · doi:10.1038/28867 · Cited by 2,502
Research works printed but not linked: 1
- Oshima M, Dinchuk JE, Kargman SL, et al. Suppression of intestinal polyposis in Apc δ716 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell 1996; 87: 803–9. · DOI
Cited by
Sorted by citations
Greenhough, A., Smartt, H. J. M., Moore, A. E., Roberts, H. R., Williams, A. C., Paraskeva, C., & Kaidi, A. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp014 · Cited by 1,220
The role of COX‐2 in intestinal inflammation and colorectal cancer
Wang, D., & DuBois, R. N. (2010) · Oncogene · doi:10.1038/onc.2009.421 · Cited by 805
Conquering the Hypoxia Limitation for Photodynamic Therapy
Wan, Y., Fu, L., Li, C., Lin, J., & Huang, P. (2021) · Advanced Materials · doi:10.1002/adma.202103978 · Cited by 705
Prabhakar, N. R., & Semenza, G. L. (2012) · Physiological Reviews · doi:10.1152/physrev.00030.2011 · Cited by 641
Oxygen-dependent regulation of mitochondrial respiration by hypoxia-inducible factor 1
Semenza, G. L. (2007) · Biochemical Journal · doi:10.1042/bj20070389 · Cited by 541
Interaction between β-catenin and HIF-1 promotes cellular adaptation to hypoxia
Kaidi, A., Williams, A. C., & Paraskeva, C. (2007) · Nature Cell Biology · doi:10.1038/ncb1534 · Cited by 529
Big opportunities for small molecules in immuno-oncology
Adams, J. L., Smothers, J. F., Srinivasan, R., & Hoos, A. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4596 · Cited by 492
Molecular Pathways Involved in Colorectal Cancer: Implications for Disease Behavior and Prevention
Colussi, D., Brandi, G., Bazzoli, F., & Ricciardiello, L. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms140816365 · Cited by 429
Metabolic Hallmarks of Tumor and Immune Cells in the Tumor Microenvironment
Renner, K., Singer, K., Koehl, G. E., Geissler, E. K., Peter, K., Siska, P. J., & Kreutz, M. P. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00248 · Cited by 384
Semenza, G. L. (2009) · WIREs Systems Biology and Medicine · doi:10.1002/wsbm.69 · Cited by 324
HIF Inhibitors: Status of Current Clinical Development
Fallah, J., & Rini, B. I. (2019) · Current Oncology Reports · doi:10.1007/s11912-019-0752-z · Cited by 308
Masson, N., & Ratcliffe, P. J. (2014) · Cancer & Metabolism · doi:10.1186/2049-3002-2-3 · Cited by 305
Cytokines, Inflammation and Colon Cancer
Klampfer, L. (2011) · Current Cancer Drug Targets · doi:10.2174/156800911795538066 · Cited by 297
HIF1A Overexpression Is Associated with Poor Prognosis in a Cohort of 731 Colorectal Cancers
Baba, Y., Nosho, K., Shima, K., Irahara, N., Chan, A. T., Meyerhardt, J. A., Chung, D. C., Giovannucci, E. L., Fuchs, C. S., & Ogino, S. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.090972 · Cited by 294
Role of hypoxia-inducible factors in breast cancer metastasis
Gilkes, D. M., & Semenza, G. L. (2013) · Future Oncology · doi:10.2217/fon.13.92 · Cited by 274
The role of hypoxia‐inducible factor 1 in tumor immune evasion
Li, Y., Wu, W., Wang, X., Fang, L., Adam, V., Nepovimová, E., Wu, Q., & Kuča, K. (2020) · Medicinal Research Reviews · doi:10.1002/med.21771 · Cited by 276
Broekgaarden, M., Weijer, R., van Gulik, T. M., Hamblin, M. R., & Heger, M. (2015) · Cancer and Metastasis Reviews · doi:10.1007/s10555-015-9588-7 · Cited by 266
MiR-101 downregulation is involved in cyclooxygenase-2 overexpression in human colon cancer cells
Strillacci, A., Griffoni, C., Sansone, P., Paterini, P., Piazzi, G., Lazzarini, G., Spisni, E., Pantaleo, M. A., Biasco, G., & Tomasi, V. (2008) · Experimental Cell Research · doi:10.1016/j.yexcr.2008.12.010 · Cited by 244
Liang, X., Chen, M., Bhattarai, P., Hameed, S., & Dai, Z. (2020) · ACS Nano · doi:10.1021/acsnano.0c05617 · Cited by 222
IDO Expression in Cancer: Different Compartment, Different Functionality?
Meireson, A., Devos, M., & Brochez, L. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.531491 · Cited by 215
Cellular and molecular mechanisms of inflammation‐induced angiogenesis
Szade, A., Grochot‐Przeczek, A., Florczyk, U., Józkowicz, A., & Dulak, J. (2015) · IUBMB Life · doi:10.1002/iub.1358 · Cited by 203
Mechanisms of adaptive angiogenesis to tissue hypoxia
Fong, G. (2008) · Angiogenesis · doi:10.1007/s10456-008-9107-3 · Cited by 212
Bagińska, J., Viry, E., Paggetti, J., Medves, S., Berchem, G., Moussay, E., & Janji, B. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00490 · Cited by 204
Hypoxia Inducible Factor-1–Independent Pathways in Tumor Angiogenesis
Mizukami, Y., Kohgo, Y., & Chung, D. C. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0111 · Cited by 189
Prostaglandin E2 and the EP receptors in malignancy: possible therapeutic targets?
O'Callaghan, G. P., & Houston, A. M. (2015) · British Journal of Pharmacology · doi:10.1111/bph.13331 · Cited by 181
Shah, Y. M., Ito, S., Morimura, K., Chen, C., Yim, S., Haase, V. H., & Gonzalez, F. J. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.03.009 · Cited by 168
Obesity and colorectal cancer: molecular features of adipose tissue
Martínez‐Useros, J., & García‐Foncillas, J. (2016) · Journal of Translational Medicine · doi:10.1186/s12967-016-0772-5 · Cited by 181
Paving the Rho in cancer metastasis: Rho GTPases and beyond
Jansen, S. R., Gosens, R., Wieland, T., & Schmidt, M. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.09.002 · Cited by 171
The Pathogenesis of Adenomyosis vis-à-vis Endometriosis
Guo, S.-W. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9020485 · Cited by 165
“Lastly, many genes, such as ERβ and cyclooxygenase-2 (COX-2), that are involved in tissue repair and inflammation, are upregulated in adenomyosis.”
InfluentialFitzpatrick, S. F., Tambuwala, M. M., Brüning, U., Schaible, B., Scholz, C. C., Byrne, A. T., O’Connor, A. E., Gallagher, W. M., Lenihan, C. R., Garvey, J., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1002256 · Cited by 156
Inflammatory pathways in the early steps of colorectal cancer development
Mariani, F. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i29.9716 · Cited by 161
Greenhough, A., Patsos, H. A., Williams, A. C., & Paraskeva, C. (2007) · International Journal of Cancer · doi:10.1002/ijc.22917 · Cited by 161
Cyclooxygenase-2 in oncogenesis
Rizzo, M. T. (2010) · Clinica Chimica Acta · doi:10.1016/j.cca.2010.12.026 · Cited by 155
Goh, J. X. H., Tan, L. T., Goh, J. K., Chan, K., Pusparajah, P., Lee, L., & Goh, B. H. (2019) · Cancers · doi:10.3390/cancers11060867 · Cited by 152
Advances in the Potential Biomarkers of Epilepsy
Kobylarek, D., Iwanowski, P. S., Lewandowska, Z., Limphaibool, N., Szafranek, S., Labrzycka, A., & Kozubski, W. P. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.00685 · Cited by 157
Boleij, A., & Tjalsma, H. (2012) · Biological reviews/Biological reviews of the Cambridge Philosophical Society · doi:10.1111/j.1469-185x.2012.00218.x · Cited by 153
Chell, S. D., Кади, А., Williams, A. C., & Paraskeva, C. (2006) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2006.05.002 · Cited by 144
The role of hypoxia-inducible factors in cancer
Maynard, M. A., & Ohh, M. (2007) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-007-7082-2 · Cited by 139
Mougiakakos, D., Johansson, C. C., Trocmé, E., All‐Ericsson, C., Economou, M. A., Larsson, O., Seregard, S., & Kiessling, R. W. (2010) · Cancer · doi:10.1002/cncr.24999 · Cited by 146
Raja, R., Kale, S., Thorat, D., Soundararajan, G., Lohite, K., Mane, A. D., Karnik, S. V., & Kundu, G. C. (2013) · Oncogene · doi:10.1038/onc.2013.171 · Cited by 136
Kim, S.-H., Park, Y., Kim, S., Lee, J., Wang, D., & DuBois, R. N. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-1262 · Cited by 132
Jang, G. Y., Jeon, J. H., Cho, S. Y., Shin, D. M., Kim, C. W., Jeong, E. M., Bae, H.-S., Kim, T. W., Lee, S. H., Choi, Y. H., et al. (2009) · Oncogene · doi:10.1038/onc.2009.342 · Cited by 128
Hypoxia activates the cyclooxygenase-2–prostaglandin E synthase axis
Lee, J. J., Natsuizaka, M., Ohashi, S., Wong, G. S., Takaoka, M., Michaylira, C. Z., Budo, D., Tobias, J. W., Kanai, M., Shirakawa, Y., et al. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp326 · Cited by 123
Bocca, C., Ievolella, M., Autelli, R., Motta, M., Mosso, L., Torchio, B., Bozzo, F., Cannito, S., Paternostro, C., Colombatto, S., et al. (2013) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2014.860447 · Cited by 119
Hypoxia Activates NF-κB–Dependent Gene Expression Through the Canonical Signaling Pathway
Oliver, K. M., Garvey, J., Ng, C. T., Veale, D. J., Fearon, U., Cummins, E. P., & Taylor, C. T. (2009) · Antioxidants and Redox Signaling · doi:10.1089/ars.2008.2400 · Cited by 120
Strillacci, A., Valerii, M. C., Sansone, P., Caggiano, C., Sgromo, A., Vittori, L., Fiorentino, M., Poggioli, G., Rizzello, F., Campieri, M., et al. (2012) · The Journal of Pathology · doi:10.1002/path.4097 · Cited by 118
Shi, J., Liu, F., ZHANG, W., Liu, X., Lin, B., & Tang, X. (2015) · Oncology Reports · doi:10.3892/or.2015.3889 · Cited by 117
Hypoxia inducible factor-1α: Its role in colorectal carcinogenesis and metastasis
Nagaraju, G. P., Bramhachari, P. V., Raghu, G., & El‐Rayes, B. F. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.06.005 · Cited by 114
He, J., Wang, M., Jiang, Y., Chen, Q., Xu, S., Xu, Q., Jiang, B., & Liu, L.-Z. (2014) · Environmental Health Perspectives · doi:10.1289/ehp.1307545 · Cited by 115
Kim, S., Seong, K.-J., Kim, W.-J., & Jung, J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23074004 · Cited by 118
Hypoxia-regulated lncRNAs in cancer
Chang, Y., Zhang, K., Hu, Z., Qi, H.-X., Shi, Z., Han, X., Han, Y., & Wei, H. (2015) · Gene · doi:10.1016/j.gene.2015.08.049 · Cited by 113
Tumor metabolism as modulator of immune response and tumor progression
Gottfried, E., Kreutz, M. P., & Mackensen, A. (2012) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2012.02.009 · Cited by 115
New Insights on COX-2 in Chronic Inflammation Driving Breast Cancer Growth and Metastasis
Hugo, H. J., Saunders, C. M., Ramsay, R. G., & Thompson, E. W. (2015) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-015-9333-4 · Cited by 108
Ahmadi, M., Emery, D. C., & Morgan, D. J. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1060 · Cited by 105
Broekgaarden, M., Weijer, R., Krekorian, M., van den IJssel, B., Kos, M., Alles, L. K., van Wijk, A. C. W. A., Bikádi, Z., Hazai, E., van Gulik, T. M., et al. (2016) · Nano Research · doi:10.1007/s12274-016-1059-0 · Cited by 101
Hypoxia and Prostate Cancer Aggressiveness: A Tale With Many Endings
Fraga, A. M., Ribeiro, R. J. T., Príncipe, P., Lopes, C., & Medeiros, R. (2015) · Clinical Genitourinary Cancer · doi:10.1016/j.clgc.2015.03.006 · Cited by 103
MacFie, T. S., Poulsom, R., Parker, A., Warnes, G., Boitsova, T., Nijhuis, A. M., Suraweera, N., Poehlmann, A., Szary, J., Feakins, R. M., et al. (2014) · Inflammatory Bowel Diseases · doi:10.1097/01.mib.0000442012.45038.0e · Cited by 103
Mechanistic Aspects of COX-2 Expression in Colorectal Neoplasia
Dixon, D. A., Blanco, F. F., Bruno, A., & Patrignani, P. (2012) · Recent results in cancer research/Recent Results in Cancer Research · doi:10.1007/978-3-642-30331-9_2 · Cited by 101
Hypoxia-inducible factor-1 (HIF-1) promotes LDL and VLDL uptake through inducing VLDLR under hypoxia
Shen, G., Zhao, Y., Chen, M., Zhang, F., Liu, X., Wang, Y., Liu, C., Yu, J., & Zhang, J. (2011) · Biochemical Journal · doi:10.1042/bj20111377 · Cited by 94
Spinella, F., Rosanò, L., Castro, V. D., Decandia, S., Nicotra, M. R., Natali, P. G., & Bagnato, A. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2606 · Cited by 96
LncRNA SNHG11 facilitates tumor metastasis by interacting with and stabilizing HIF-1α
Xu, L., Huan, L., Guo, T., Wu, Y., Liu, Y., Wang, Q., Huang, S., Xu, Y., Liang, L., & He, X. (2020) · Oncogene · doi:10.1038/s41388-020-01512-8 · Cited by 90
Oxygen-Independent Stabilization of Hypoxia Inducible Factor (HIF)-1 during RSV Infection
Haeberle, H. A., Dürrstein, C., Rosenberger, P., Hosakote, Y. M., Kuhlicke, J., Kempf, V. A. J., Garofalo, R. P., & Eltzschig, H. K. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003352 · Cited by 89
Stewart, G. D. (1994) · Oncology Reports · doi:10.3892/or_00000180 · Cited by 89
Noordhuis, M. G., Eijsink, J. J. H., Roossink, F., de Graeff, P., Pras, E., Schuuring, E. M. D., Wisman, G. B. A., de Bock, G. H., & van der Zee, A. G. J. (2011) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2010.09.043 · Cited by 89
Targets for protection and mitigation of radiation injury
Khodamoradi, E., Hoseini‐Ghahfarokhi, M., Amini, P., Motevaseli, E., Shabeeb, D., Musa, A. E., Najafi, M., & Farhood, B. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03479-x · Cited by 88
Prostaglandin E2 in the Tumor Microenvironment, a Convoluted Affair Mediated by EP Receptors 2 and 4
Santiso, A., Heinemann, Á., & Kargl, J. (2024) · Pharmacological Reviews · doi:10.1124/pharmrev.123.000901 · Cited by 92
NFκB and HIF display synergistic behaviour during hypoxic inflammation
Brüning, U., Fitzpatrick, S. F., Frank, T. D., Birtwistle, M. R., Taylor, C. T., & Cheong, A. (2011) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-011-0876-2 · Cited by 85
Hypoxia‐inducible factor‐1 as a therapeutic target in cancer
Tang, C., & Yu, J. Q. (2012) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.12038 · Cited by 80
Hypoxia stimulus: An adaptive immune response during dendritic cell maturation
Rama, I., Brüne, B., Torrás, J., Koehl, R., Cruzado, J. M., Bestard, O., Franquesa, M., Lloberas, N., Weigert, A., Herrero, I., et al. (2008) · Kidney International · doi:10.1038/sj.ki.5002792 · Cited by 80
The role of the tissue omega-6/omega-3 fatty acid ratio in regulating tumor angiogenesis
Kang, J. X., & Liu, A. (2012) · Cancer and Metastasis Reviews · doi:10.1007/s10555-012-9401-9 · Cited by 79
Gómez‐Valenzuela, F., Escobar, E., Pérez‐Tomás, R., & Montecinos, V. P. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.686792 · Cited by 79
Wu, S., Kasim, V., Kano, M. R., Tanaka, S., Ohba, S., Miura, Y., Miyata, K., Liu, X., Matsuhashi, A., Chung, U., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-0366 · Cited by 78
Hsu, H.-H., Chen, M., Day, C. H., Lin, Y.-M., Li, S.-Y., Tu, C., Padma, V. V., Shih, H.-N., Kuo, W., & Huang, C. (2017) · World Journal of Gastroenterology · doi:10.3748/wjg.v23.i7.1171 · Cited by 75
Xue, X., & Shah, Y. M. (2012) · Carcinogenesis · doi:10.1093/carcin/bgs313 · Cited by 75
Jayaraman, T., Tejero, J., Chen, B. B., Blood, A. B., Frizzell, S., Shapiro, C., Tiso, M., Hood, B. L., Wang, X., Zhao, X., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.271973 · Cited by 73
Ullrich, N., Schröder, A., Jantsch, J., Spanier, G., Proff, P., & Kirschneck, C. (2019) · International Journal of Oral Science · doi:10.1038/s41368-019-0066-x · Cited by 69
Law, P. C., Au-Yeung, K. K. W., Chan, L.-Y., & Ko, J. K.-S. (2012) · BMC Complementary and Alternative Medicine · doi:10.1186/1472-6882-12-160 · Cited by 69
Signaling pathways in intestinal homeostasis and colorectal cancer: KRAS at centre stage
Ternet, C., & Kiel, C. (2021) · Cell Communication and Signaling · doi:10.1186/s12964-021-00712-3 · Cited by 73
Astrocytes propel neurovascular dysfunction during cerebral cavernous malformation lesion formation
Lopez‐Ramirez, M. A., Soliman, S. I., Hale, P., Lai, C. C., PHAM, A., Estrada, E. J., McCurdy, S., Girard, R., Verma, R., Moore, T., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci139570 · Cited by 70
Potential Targets for Colorectal Cancer Prevention
Temraz, S. N., Mukherji, D., & Shamseddine, A. I. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms140917279 · Cited by 66
Huang, M., Wang, L., Chen, J., Bai, M., Zhou, C., Liu, S., & Lin, Q. (2016) · International Journal of Oncology · doi:10.3892/ijo.2016.3421 · Cited by 65
HIF-1α in colorectal carcinoma: review of the literature.
Ιωάννου, Μ., Paraskeva, E., Baxevanidou, K., Simos, G., Papamichali, R., Papacharalambous, C., Σαμαρά, Μ., & Koukoulis, G. Κ. (2015) · PubMed · Cited by 64
Tsai, Y.-T., Lo, W., Chen, P., Ko, C., Chuang, J., Kao, T., Yang, W., Chang, K., Hung, C.-Y., Kikkawa, U., et al. (2022) · Journal of Biomedical Science · doi:10.1186/s12929-022-00804-3 · Cited by 63
Hypoxia pathway proteins and their impact on the blood vasculature
Rodriguez, D., Watts, D., Gaete, D., Sormendi, S., & Wielockx, B. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22179191 · Cited by 62
Jin, F., Yang, R., Yao, W., Wang, D., Zhu, Y., Wang, X., Lu, Y., Wang, Y., Zen, K., & Li, L. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.10.025 · Cited by 61
Aloe-emodin suppresses hypoxia-induced retinal angiogenesis via inhibition of HIF-1α/VEGF pathway
Wu, J., Ke, X., Wang, W., Zhang, H., Ma, N., Fu, W., Zhao, M., Gao, X., Hao, X., & Zhang, Z. (2016) · International Journal of Biological Sciences · doi:10.7150/ijbs.16334 · Cited by 61
MiRNA‐26b regulates the expression of cyclooxygenase‐2 in desferrioxamine‐treated CNE cells
Ji, Y., He, Y., Liu, L., & Zhong, X. (2010) · FEBS Letters · doi:10.1016/j.febslet.2010.01.036 · Cited by 60
Mariani, F., Sena, P., Marzona, L., Riccio, M., Fano, R. A., Manni, P., Gregorio, C. D., Pezzi, A., de Leòn, M. P., Monni, S., et al. (2009) · Cancer Letters · doi:10.1016/j.canlet.2009.02.001 · Cited by 59
Small molecules as theranostic agents in cancer immunology
Li, J., Valkenburgh, J. S. V., Hong, X., Conti, P. S., Zhang, X., & Chen, K. (2019) · Theranostics · doi:10.7150/thno.37218 · Cited by 61
Contribution of hypoxia inducible factor-1 during viral infections
Reyes, A., Corrales, N., Gálvez, N. M. S., Bueno, S. M., Kalergis, A. M., & González, P. A. (2020) · Virulence · doi:10.1080/21505594.2020.1836904 · Cited by 58
Gandhi, S., & Chandna, S. (2017) · Cancer and Metastasis Reviews · doi:10.1007/s10555-017-9669-x · Cited by 60
Metabolic Control of Epigenetics and Its Role in CD8+ T Cell Differentiation and Function
Yerinde, C., Siegmund, B., Glauben, R., & Weidinger, C. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02718 · Cited by 61
Lim, W., Park, C., Shim, M. K., Lee, Y. H., Lee, Y., & Lee, Y. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12491 · Cited by 60
Roy, A., Zhang, M., Saad, Y., & Kolattukudy, P. E. (2013) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00203.2013 · Cited by 58
Muraki, C., Ohga, N., Hida, Y., Nishihara, H., Kato, Y., Tsuchiya, K., Matsuda, K., Totsuka, Y., Shindoh, M., & Hida, K. (2011) · International Journal of Cancer · doi:10.1002/ijc.25976 · Cited by 57
Flannigan, K. L., Agbor, T. A., Motta, J., Ferraz, J. G., Wang, R., Buret, A. G., & Wallace, J. L. (2014) · The FASEB Journal · doi:10.1096/fj.14-266015 · Cited by 57
Wu, J., Xiao, K., Ma, N., Wang, W., Fu, W., Zhang, H., Zhao, M., Gao, X., Hao, X., & Zhang, Z. (2016) · Drug Design Development and Therapy · doi:10.2147/dddt.s114022 · Cited by 57
The Eicosanoids, Redox-Regulated Lipid Mediators in Immunometabolic Disorders
de Araújo, A. C. J., Wheelock, C. E., & Haeggström, J. Z. (2017) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7332 · Cited by 58
The Crosstalk of PTGS2 and EGF Signaling Pathways in Colorectal Cancer
Wang, D., Xia, D., & DuBois, R. N. (2011) · Cancers · doi:10.3390/cancers3043894 · Cited by 55
Kim, S.-H., Xia, D., Kim, S.-W., Holla, V. R., Menter, D. G., & DuBois, R. N. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-2110 · Cited by 54
Metadata
- Authors
- Kaidi, A., Qualtrough, D., Williams, A. C., & Paraskeva, C.
- Affiliations
- Cancer Research UK (GB)
- Venue
- Cancer Research
- Published
- 2006-07-01
- Volume
- 66
- Issue
- 13
- Pages
- 6683-6691
- ISSN
- 0008-5472 (ISSN-L)
- 1538-7445
- OpenAlex
- W2008854828
- Cited by
- 300
- References
- 49
- Citations by year
- 2026: 3 · 2025: 6 · 2024: 10 · 2023: 6 · 2022: 13 · 2021: 17 · 2020: 24 · 2019: 18 · 2018: 13 · 2017: 16 · 2016: 17 · 2015: 23 · 2014: 16 · 2013: 19 · 2012: 22
- FWCI
- 7.73
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Cancer Research (publishedVersion)
- PubMed (publishedVersion)
- Bristol Research (University of Bristol) (publishedVersion)
- Explore Bristol Research (submittedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
- Keywords
- cyclooxygenase-2, hypoxia-inducible factor-1α, colorectal cancer, colorectal adenoma, hypoxia, prostaglandin E2, hypoxia response element, transcriptional regulation, vascular endothelial growth factor, MAPK signaling, tumor cell survival, angiogenesis, COX-2 selective inhibitors, tumor microenvironment
- MeSH terms
- Base Sequence, Cell Survival, Humans, Molecular Sequence Data, Promoter Regions, Genetic, Transcription, Genetic, Colorectal Neoplasms, Dinoprostone, Cell Hypoxia, Up-Regulation, Gene Expression Regulation, Enzymologic, Gene Expression Regulation, Neoplastic, HT29 Cells, MAP Kinase Signaling System, HCT116 Cells, Cell Growth Processes, Cyclooxygenase 2, Hypoxia-Inducible Factor 1, alpha Subunit
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
